Translational Innovator: The Science Behind Recurring C. Difficile Infections

"The pathogen c.diff recurs in approximately 25% of patients within two months," says Georg Gerber, PhD, Brigham and Women's Hospital. In this podcast, Gerber reflects on the impact funding received from Harvard Catalyst has had on his research which focuses on recurring infections.